Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 2/20 | 0.74 |
| ▸ | CNR2 | P34972 | 11/20 | 0.59 |
| ▸ | CNR1 | P21554 | 8/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31546114 | 1.00 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388532 | 1.00 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545238 | 1.00 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388428 | 0.99 | DRD3 (0.72) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545930 | 0.99 | DRD3 (0.72) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545000 | 0.97 | DRD3 (0.71) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388682 | 0.97 | DRD3 (0.71) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388506 | 0.93 | DRD3 (0.68) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545575 | 0.93 | DRD3 (0.68) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388117 | 0.90 | CNR2 (0.73) | DRD3CNR2CNR1NR1I2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580400-B2 | Cannabinergic nitrate esters and related analogs | NORTHEASTERN UNIVERSITY (US) | 2017-02-28 | — | — | US | disclosed |
| US-20160002195-A1 | CANNABINERGIC NITRATE ESTERS AND RELATED ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002195-A1 | CANNABINERGIC NITRATE ESTERS AND RELATED ANALOGS | CNR2, CNR1, CHRNB3 | DRD3 552/4885CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.